Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9V77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,935
Award facts
- Contract value 100% obligated
- $22,934.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $22,934.82 for Zepbound 2.5 mg/0.5 mL pen (0.5 mL) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was awarded without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the Defense Logistics Agency Medical Supply Chain's procurement of modern pharmaceutical therapies for military and federal healthcare systems.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors. The parent company, Cencora, holds a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 31, 2031. These comprehensive contract vehicles enable both entities to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F9V77?
SPE2DR26F9V77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9V77 worth?
The government has obligated $22,935 on SPE2DR26F9V77.
Is contract SPE2DR26F9V77 an order under another contract?
Yes. SPE2DR26F9V77 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V77 competed?
The extent of competition for SPE2DR26F9V77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award